FR2306993A1 - Procede de preparation de cephalosporines cristallines, steriles et stables pour administration parenterale - Google Patents

Procede de preparation de cephalosporines cristallines, steriles et stables pour administration parenterale

Info

Publication number
FR2306993A1
FR2306993A1 FR7609360A FR7609360A FR2306993A1 FR 2306993 A1 FR2306993 A1 FR 2306993A1 FR 7609360 A FR7609360 A FR 7609360A FR 7609360 A FR7609360 A FR 7609360A FR 2306993 A1 FR2306993 A1 FR 2306993A1
Authority
FR
France
Prior art keywords
cephalosporins
sterile
crystalline
stable
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7609360A
Other languages
English (en)
Other versions
FR2306993B1 (fr
Inventor
Michael David Cise
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of FR2306993A1 publication Critical patent/FR2306993A1/fr
Application granted granted Critical
Publication of FR2306993B1 publication Critical patent/FR2306993B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7609360A 1975-04-11 1976-03-31 Procede de preparation de cephalosporines cristallines, steriles et stables pour administration parenterale Granted FR2306993A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/567,224 US4029655A (en) 1975-04-11 1975-04-11 Method of preparing stable sterile crystalline cephalosporins for parenteral administration

Publications (2)

Publication Number Publication Date
FR2306993A1 true FR2306993A1 (fr) 1976-11-05
FR2306993B1 FR2306993B1 (fr) 1978-11-17

Family

ID=24266257

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7609360A Granted FR2306993A1 (fr) 1975-04-11 1976-03-31 Procede de preparation de cephalosporines cristallines, steriles et stables pour administration parenterale

Country Status (11)

Country Link
US (2) US4029655A (fr)
JP (1) JPS51123813A (fr)
BE (1) BE840280A (fr)
CA (1) CA1068680A (fr)
DE (1) DE2614668C2 (fr)
ES (1) ES446906A1 (fr)
FR (1) FR2306993A1 (fr)
GB (1) GB1537874A (fr)
IE (1) IE42955B1 (fr)
IL (1) IL49073A (fr)
NL (1) NL7603659A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2421905A1 (fr) * 1977-11-24 1979-11-02 Lilly Co Eli Preparation d'une poudre de cephalothine-sodiu m stable, pour administration parenterale

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996355A (en) * 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
IL53427A0 (en) * 1976-11-24 1978-01-31 Lilly Co Eli Method of preparing a rapidly dissolving powder of sterile crystalline cefozolin sodium for parenteral administration
US4115644A (en) * 1977-09-19 1978-09-19 Eli Lilly And Company Process for preparing pure cefamandole from alkali metal and ammonium salts thereof
US4132848A (en) * 1977-11-03 1979-01-02 Eli Lilly And Company Method of preparing a rapidly dissolving powder of crystalline cephalothin sodium for parenteral administration
JPS54147917A (en) * 1978-05-08 1979-11-19 Sumitomo Chem Co Ltd Ferrze-drying method
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
JPS60120886A (ja) * 1983-12-02 1985-06-28 Takeda Chem Ind Ltd セフェムカルボン酸のナトリウム塩の結晶
JPH06786B2 (ja) * 1984-02-22 1994-01-05 塩野義製薬株式会社 セフアロチンナトリウムの結晶性凍結乾燥製剤の製造法
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US4714760A (en) * 1985-08-20 1987-12-22 Bristol-Myers Company Cephalosporin intermediates
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
GB8808433D0 (en) * 1988-04-11 1988-05-11 Merck Sharp & Dohme Therapeutic agents
TW264475B (fr) * 1991-09-20 1995-12-01 Takeda Pharm Industry Co Ltd
DE69528166T2 (de) * 1994-05-02 2003-04-30 Shionogi & Co., Ltd. Kristalline pyrrolidylthiocarbapenem derivate, lyophilisierste präparationen dieser kristalle und verfahren zu deren herstellung
MXPA06012215A (es) * 2004-04-22 2007-04-19 Pfizer Prod Inc Metodo de estabilizacion de la sal sodica cefovecina desordenada.
CN101759708B (zh) * 2008-12-23 2012-07-04 深圳信立泰药业股份有限公司 头孢地嗪钠晶型及其制备方法和含有该晶型的药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3085884A (en) * 1958-07-28 1963-04-16 Liquefreeze Company Inc Method of freezing and shipping foodstuffs
GB1234802A (en) * 1968-04-19 1971-06-09 British American Tobacco Co Improvements relating to the packing of liquids
US3725003A (en) * 1969-11-04 1973-04-03 Moore Perk Corp Method of sterile packaging

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2421905A1 (fr) * 1977-11-24 1979-11-02 Lilly Co Eli Preparation d'une poudre de cephalothine-sodiu m stable, pour administration parenterale

Also Published As

Publication number Publication date
IL49073A (en) 1979-03-12
ES446906A1 (es) 1977-05-16
US4029655A (en) 1977-06-14
BE840280A (fr) 1976-10-01
GB1537874A (en) 1979-01-04
IL49073A0 (en) 1976-04-30
FR2306993B1 (fr) 1978-11-17
US4104391A (en) 1978-08-01
IE42955B1 (en) 1980-11-19
DE2614668C2 (de) 1986-10-30
DE2614668A1 (de) 1976-10-21
JPS51123813A (en) 1976-10-28
CA1068680A (fr) 1979-12-25
NL7603659A (nl) 1976-10-13
IE42955L (en) 1976-10-11
JPS6143356B2 (fr) 1986-09-26

Similar Documents

Publication Publication Date Title
FR2306993A1 (fr) Procede de preparation de cephalosporines cristallines, steriles et stables pour administration parenterale
FR2328718A1 (fr) Procede microbiologique de preparation de 9a-hydroxyandrostene-dione
BE861172A (fr) Procede de preparation d'alpha-amino-amides
BE839682A (fr) Procede de preparation de trihydrate d'amoxicilline
PT65602B (fr) Nouveau procede de preparation d'azines
BE834443A (fr) Procede de preparation de cyclohexane-diones-1,3 et d'alkyl-6-dihydro-3,4 -pyranones-2
FR2335522A1 (fr) Procede de preparation d'androstene-4 diones-3,17
BE857138A (fr) Derives peptidiques, procede pour leur preparation et compositions therapeutiques contenant ces composes
FR2309514A1 (fr) Procede de preparation d'acetoacetyl-arylamides
FR2314192A1 (fr) Procede de preparation d'oxaphospholannes-1,2
BE817761A (fr) Procede de preparation d'o-benzyltoluenes
BE837677A (fr) Procede de preparation de composes organo-stanniques
BE845327A (fr) Procede de preparation de 4,4'-dihydroxy-3-3'-5-5'-tretralcoyldiphenylalcanes
BE843288A (fr) Procede de preparation d'indoloquinolizines
BE852208A (fr) Procede ameliore pour la preparation de compositions nutrives
FR2314720A1 (fr) Nouveaux derives de cephalosporines, leurs intermediaires et procede pour leur preparation
FR2307781A1 (fr) Procede de preparation d'acenaphtenes
BE844901A (fr) Procede de preparation de l'echinenone
FR2334654A1 (fr) Procede de preparation d'halogeno-nitrobenzenes
BE830469A (fr) Procede de preparation d'acetoxybutanal
FR2317302A1 (fr) Procede de preparation d'antibiotiques du type b-lactame
BE822618A (fr) Nouveau procede de preparation de l'antibiotique
FR2317307A1 (fr) Procede de preparation d'oxaphospholannes-1,2
BE830366A (fr) Procede de preparation d'orethannes aromatiques
FR2275532A1 (fr) Procede de preparation de composes de 4-halo-4', 4'' - diarylamino - triphenyl-methanes symetriques

Legal Events

Date Code Title Description
ST Notification of lapse